Novel surface display system for proteins on non-genetically modified gram-positive bacteria by Bosma, T et al.
  
 University of Groningen
Novel surface display system for proteins on non-genetically modified gram-positive bacteria
Bosma, T; Kanninga, R; Neef, J; Audouy, SAL; van Roosmalen, ML; Steen, A; Buist, G; Kok,
J; Kuipers, OP; Robillard, G
Published in:
Applied and environmental microbiology
DOI:
10.1128/AEM.72.1.880-889.2006
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2006
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Bosma, T., Kanninga, R., Neef, J., Audouy, SAL., van Roosmalen, ML., Steen, A., ... Leenhouts, K. (2006).
Novel surface display system for proteins on non-genetically modified gram-positive bacteria. Applied and
environmental microbiology, 72(1), 880-889. https://doi.org/10.1128/AEM.72.1.880-889.2006
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, Jan. 2006, p. 880–889 Vol. 72, No. 1
0099-2240/06/$08.000 doi:10.1128/AEM.72.1.880–889.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Novel Surface Display System for Proteins on Non-Genetically
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A novel display system is described that allows highly efficient immobilization of heterologous proteins on
bacterial surfaces in applications for which the use of genetically modified bacteria is less desirable. This
system is based on nonliving and non-genetically modified gram-positive bacterial cells, designated gram-
positive enhancer matrix (GEM) particles, which are used as substrates to bind externally added heterologous
proteins by means of a high-affinity binding domain. This binding domain, the protein anchor (PA), was
derived from the Lactococcus lactis peptidoglycan hydrolase AcmA. GEM particles were typically prepared from
the innocuous bacterium L. lactis, and various parameters for the optimal preparation of GEM particles and
binding of PA fusion proteins were determined. The versatility and flexibility of the display and delivery
technology were demonstrated by investigating enzyme immobilization and nasal vaccine applications.
Heterologous display of proteins or peptides on the surface
of bacteria is a useful research tool and has been associated
with a broad range of interesting applications, including devel-
opment of live vaccine delivery systems, diagnostics, whole-cell
absorbents, and novel biocatalysts (16). For gram-positive bac-
teria, Hansson et al. (11) were the first to describe anchoring of
heterologous proteins on the surface of Staphylococcus xylosus
by translational fusion of the recombinant proteins to the
LPXTG cell wall-anchoring motif of staphylococcal protein A
(SpA). This anchoring mechanism requires processing by a
sortase for covalent anchoring of the protein to the peptidogly-
can of the bacterial cell wall (37). Various other anchoring
proteins have also been exploited for surface display, but in all
cases expressed proteins were anchored to the producer cells,
thus making the host strain for surface display a genetically
modified organism (GMO) (10, 36). However, the use of
GMOs in applications that involve uncontrolled release into
the environment (e.g., in foods and vaccines) is less desirable
or at least still being debated.
Noncovalent binding domains have the potential to be used
in trans for the binding of chimeric proteins to non-GMOs. An
example of such a domain is the C-terminal cell wall-binding
domain of lysostaphin produced by Staphylococcus simulans.
However, most if not all of this type of binding domains seem
to be species specific in their targeting and therefore have
limited use (27). Here, we report on the development of a
novel surface display tool suitable for a broad range of gram-
positive bacteria that avoids the use of GMOs in the final
application. This tool is based on the peptidoglycan-binding
domain of the major autolysin AcmA of Lactococcus lactis (5)
that enables functional display of heterologous proteins on the
surface of genetically unmodified gram-positive bacteria (4).
The cell wall-binding domain was designated the protein an-
chor (PA). The PA comprises three LysM motifs consisting of
about 45 amino acids separated by spacer sequences. The
LysM motif is a common module found in many cell wall-
degrading enzymes and proteins involved in bacterial patho-
genesis. The LysM motif has also been found in a number of
eukaryotic proteins (2). Furthermore, it was recently demon-
strated that LysM domains are involved in plant recognition of
symbiotic bacteria (22, 24, 30). It has been proposed that the
LysM-type cell wall-binding domain binds noncovalently to
peptidoglycans of various gram-positive bacteria (39). Follow-
ing secretion of the lactococcal AcmA, the PA directs the
protein to the cell wall. Hybrid PA fusions exhibited similar
properties, as has been demonstrated for MSA2, -lactamase,
-amylase, viral capsid proteins, and FedF-PA fusions (4, 17,
23, 31). It was observed in all cases that only a small amount of
the secreted PA fusion bound to the L. lactis producer cells.
Most of the secreted PA-fusion protein remained in the cul-
ture supernatant. In some cases it was demonstrated that the
PA fusions in the growth medium could be used in trans to bind
to nonproducer L. lactis cells, albeit again in small amounts
(31, 39). Steen et al. (39) discovered that boiling of L. lactis
whole cells in trichloroacetic acid (TCA) followed by washing
and neutralization prior to binding dramatically increased the
amount of MSA2-PA that can be bound to the cells.
Here, we found that several acids can be used for pretreat-
ment of L. lactis cells in order to enhance the binding of PA
fusions. The acid-pretreated nonliving lactococcal cells were
designated “gram-positive enhancer matrix (GEM) particles,”
and they may provide a suitable non-GMO support for PA-
mediated cell surface display of all kinds of heterologous pro-
teins. Therefore, we constructed a generally applicable surface
display system based on lactococcal GEM particles and the PA.
We optimized the conditions for preparation of GEM parti-
cles, analyzed their DNA and protein contents, and deter-
mined the maximum loading capacity for PA fusions. In addi-
tion, the influence of the number of PA LysM motifs in the PA
on binding efficiency was determined, and LysM-containing
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motifs of other proteins were tested for the ability to bind to
lactococcal GEM particles.
Moreover, we constructed a versatile lactococcal PA display
vector that allows efficient inducible expression and secretion
of PA fusions into the culture medium. The addition of cell-
free culture medium containing a PA fusion to lactococcal
GEM particles results in efficient, strong, and selective surface
binding of the chimeric anchor fusion protein without a need
for additional purification steps. To demonstrate the applica-
bility of this display system, two biocatalysts, -amylase and
-lactamase, were functionally displayed in different ratios on
the surface of L. lactis GEM particles. Furthermore, we found
that PA-mediated surface display of epitopes of the Plasmo-
dium berghei malaria circumsporozoite protein antigen on L.
lactis GEM particles induces high levels of immunoglobulin G
(IgG)-specific serum antibodies in nasally immunized mice.
Altogether, this system provides a cheap, flexible, effective,
easy-to-handle alternative for surface display of proteins and
peptides on non-genetically modified bacteria.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Strains and plasmids used in this
study are listed in Table 1. L. lactis strains were grown at 30°C in M17 broth
(Oxoid) containing 0.5% (wt/vol) glucose (GM17) and, when necessary, supple-
mented with chloramphenicol (5 g/ml) or erythromycin (5 g/ml) for plasmid
selection. Induction for PnisA-driven gene expression was done with the culture
supernatant of the nisin-producing organism L. lactis strain NZ9700 as described
previously (14). Lactobacillus spp. were grown in MRS broth (Oxoid) in standing
cultures at 30°C. Bacillus subtilis was grown aerobically in TY broth at 37°C.
Mycobacterium smegmatis was grown aerobically in Middlebrook medium (Ox-
oid) at 37°C. Escherichia coli strains were grown in Luria-Bertani liquid medium
or on agar plates at 37°C; both media were supplemented with 100 g/ml
ampicillin.
General molecular biology. Unless specified otherwise, all protein analysis and
standard recombinant DNA techniques were performed as described previously
(35) or as specified by the manufacturers. Enzymes and buffers were purchased
from New England Biolabs or Roche. Electrotransformation of L. lactis was
carried out as described previously (12) using a Bio-Rad Gene Pulser (Bio-Rad).
Nucleotide sequence analyses were performed by BaseClear (Leiden, The Neth-
erlands).
The PA6 concatemer constructs were made as follows. The first LysM repeat
of the AcmA protein anchor (nucleotides 819 to 1038) was amplified by PCR
using oligonucleotides cA1repeat1.fw (5-CCGTCTCCAATTGGAGCTTCTTC
AGCTGGAAATAC) and cA1repeat1.rev (TAATAAGCTTAAAGGTCTCCA
ATTCCTGTCAGTACAAGTTTTTGACCAATG). The resulting amplification
product had at the 5 end an Esp3I site that generated EcoRI sticky ends. The
3 end contained an Eco31I site that generated EcoRI sticky ends and 3 of that
a HindIII site. The amplicon was digested with Esp3I and HindIII and ligated
into pPA3 that was digested with EcoRI and HindIII, yielding plasmid pPA6.
Successive PA6 modules were added by ligating the Esp3I (which generated an
EcoRI sticky end)/HindIII-digested amplification product into pPA6 digested
with Eco31I (which generated a EcoRI sticky end) and HindIII. After ligation,
the Eco31I recognition site in the vector was lost, but a new one was introduced
with insertion of the PCR fragment, which allowed insertion of the following
LysM PCR fragment.
RTQ-PCR. An E. coli plasmid containing the lactococcal htrA gene (pTOPO-
htrA) was used as a standard. The number of htrA copies was derived from the
DNA concentration of the isolated pTOPO-htrA, which was measured spectro-
photometrically at 260 nm. A standard real-time quantitative PCR (RTQ-PCR)
was performed with 102 to 108 htrA copies per PCR mixture.
Primers HtrA.5 (5-GAGGATATCATAATCATCCTCAG) and HtrA.6 (5-
GTCGGCTCACCTTTAGGTAG) (Sigma-Genosys) were used to target the
htrA gene. In a conventional PCR these primers yielded a single specific 0.9-kb
amplicon with total DNA of L. lactis or plasmid pTOPO-htrA as the template.
RTQ-PCR was performed with 1 l of total DNA isolated from 2.5  109
nontreated L. lactis cells or lactococcal GEM particles using an iCycler IQ
real-time PCR detection system (Bio-Rad). Total DNA was isolated as described
by Leenhouts et al. (19), with one modification: cell pellets were lysed in 0.5%
sodium dodecyl sulfate (SDS) after incubation with lysozyme (2 mg/ml) and
mutanolysin (15 U) at 55°C for 15 min. The reaction mixtures (total volume, 25
l) contained IQSYBR Green Supermix (Bio-Rad) and 2 M of each primer.
The temperature program consisted of one cycle of 95°C for 60 s, followed by 40
cycles of 60 s at 95°C, 60 s at 50°C, and 60 s at 72°C for data acquisition. To
evaluate the specificity of the amplification, a melting curve was determined over
the range from 60°C to 95°C with increments of 0.5°C for 10 s. Standard samples
were included in each run to establish a standard curve. The iCycler IQ software
(Bio-Rad) was used for data analysis.
L. lactis pretreatments and binding conditions. Chemical pretreatment of L.
lactis NZ9000(acmA) was routinely done with 10% trichloroacetic acid (TCA)
(0.6 M) as follows. Cells of stationary-phase cultures were collected by centrif-
ugation and washed once with 0.5 volume of phosphate-buffered saline (PBS) (58
mM Na2HPO4 · 2H2O, 17 mM Na2H2PO4 · H2O, 68 mM NaCl; pH 7.2). Cells
were resuspended in 0.2 volume of a 10% TCA solution and boiled for 30 min.
Subsequently, the GEM particles formed in this way were washed three times
with PBS and resuspended in PBS so that the average concentration was 2.5 
1010 GEM particles/ml, as determined with a Burker-Turk hemocytometer.
GEM particles were either used immediately for binding experiments or stored
in 0.5-ml aliquots at 80°C until use. The following chemicals and conditions
were used to examine the effect of pretreatment on the binding capacity of L.
lactis cells for PA fusion proteins: 0.2 M TCA, 0.01 M hydrochloric acid (HCl),
5.6 M acetic acid (HAc), 0.72 M lactic acid, 10% SDS, and 4 M guanidine
hydrochloride. An alternative pretreatment was performed with Tris-buffered
phenol for 15 min at 55°C. The effects of the pretreatments on viability were
analyzed by recovery and plating of the cells under the conditions used after
electroporation of L. lactis cells (12).
In a typical binding experiment 2.5 109 GEM particles were incubated for 30
to 60 min at room temperature in an end-over-end rotator with 0.5 to 50 ml of
cell-free culture medium containing a PA fusion protein. The fusions used in this
study, listed in Table 1, all contained the PA at the C terminus of the protein.
When appropriate, culture medium containing PA fusions was concentrated
prior to binding using a Vivaflow 200 (Vivascience, Germany). After binding,
GEM particles were collected by centrifugation, washed twice with PBS, and
analyzed by SDS-polyacrylamide gel electrophoresis (PAGE), immunoblotting,
or enzymatic activity analysis.
Protein purification and analysis. PA3 was purified essentially as described
previously (39). SDS-PAGE was carried out by using standard procedures (15).
After separation, proteins were either stained with Coomassie brilliant blue or
electroblotted on polyvinylidene difluoride membranes (Roche). In immuno-
blots, PA fusions were detected with horseradish peroxidase-conjugated anti-c-
myc antibody (Roche). The membrane was developed with a 3-amino-g-ethyl-
carbazole (AEC)/H2O2 substrate solution (Sigma) in 20 ml 100 mM HAc-NaOH
(pH 5.0), as specified by the manufacturer.
The amount of PA6 concatemers was determined densitometrically by analysis
of scans of Coomassie brilliant blue-stained SDS–12.5% polyacrylamide (PAA)
gels with the Total Lab image analysis software, version 1.0 (Non Linear Dy-
namics, United Kingdom). A calibration curve was generated using bovine serum
albumin (BSA) protein standards on the same PAA gel.
For His tag isolation of CSP[2xB]-His, E. coli BL21DE3(pPA193) was cultured
in 1 liter growth medium and induced with 0.5 mM isopropyl--D-thiogalacto-
pyranoside (IPTG) at an optical density at 600 nm of 	0.5. Cells were harvested
2 h after induction, resuspended in lysis buffer (50 mM Tris-HCl, 50 mM NaCl;
pH 8.0), and disrupted by two passages through a One Shot cell disruptor
(Constant Systems, United Kingdom) at 2,500  105 Pa. Cleared lysate was
applied to Ni-nitrilotriacetic acid resin prewashed with binding buffer (300 mM
NaCl, 50 mM NaH2PO4, 10 mM imidazole; pH 8.0), and His-tagged protein was
eluted in elution buffer (binding buffer with 100 mM NaCl and 240 mM imida-
zole). Fractions containing CSP[2xB]-His were pooled and subjected to buffer
exchange against water with a HiPrep 26/10 column (Pharmacia). A total of 13
mg purified CSP[2xB]-His was obtained in this way.
Enzyme assays. The enzyme activities of bound -amylase– and -lacta-
mase–PA fusions (-PA and -PA, respectively) were measured colorimetrically.
GEM particles loaded with both enzymes were spun down and washed twice with
PBS. -Amylase activity was determined by incubating the loaded GEM particles
in 1 ml of an amylose azure (Sigma) substrate solution (0.6 mg/ml amylose azure
in 20 mM K2HPO4/KH2PO4 buffer containing 50 mM NaCl [pH 7.5]) at 37°C
and 200 rpm. After 60 min, GEM particles and insoluble amylose azure were
spun down, and the absorbance at 595 nm was determined.
-Lactamase activity was measured by adding 40 l nitrocefin (CalBiochem)
to GEM particles loaded with -PA in 1 ml (final volume) of PBS. After 30 min
the absorbance at 486 nm was determined.
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Microscopy. For immunofluorescence microscopy, suspensions containing 100
l of GEM particles incubated with a PA fusion were washed twice with demin-
eralized water and resuspended in an equal volume of PBS containing 1% BSA
and mouse anti-c-myc antibody that was diluted 1:50. After incubation for 1 h at
room temperature, the particles were washed three times with 1 ml PBS. Sub-
sequently, they were incubated with 1 volume of PBS containing 1% BSA and
Oregon Green-labeled goat anti-mouse immunoglobulin (Molecular Probes)
diluted 1:100. After one wash with 2 volumes of PBS and two washes with 2
volumes of demineralized water, the GEM particles were resuspended in 100 l
demineralized water. A 10-l aliquot of the suspension was spread onto a polysin
microslide (Menzel-Gla¨ser) and air dried. After application of 8 l Vectashield
(Vector, Burlingame, CA) and mounting of a coverslip, the samples were exam-
ined by fluorescence microscopy using a Zeiss microscope (Carls Zeiss, Thorn-
wood, CA) and an Axion Vision camera (Axion Technologies, Houston, TX).
MSA2-PA was detected by fluorescence microscopy using anti-MSA2 polyclonal
rabbit serum (32) and Oregon Green-conjugated goat anti-rabbit immunoglob-
ulin with HL specificity (Molecular Probes) as the secondary antibody.
For transmission electron microscopy, samples were fixed by adding glutaral-
dehyde (Fluka) to a final concentration of 0.1%. After 3 h of fixation at 0°C the
material was washed with 0.1 M sodium cacodylate (CAC buffer) (pH 7.2) and
postfixed for 2 h in a solution containing 1% osmium tetroxide and 5% sodium
bichromate in CAC buffer. Subsequently, the specimens were stained overnight
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant phenotype(s) or genotype(s)a Source or reference
Strains
E. coli BL21DE3 Allows IPTG-inducible expression Novagen
E. coli TOP10 Cloning host Invitrogen
L. lactis MG1363 Plasmid-free derivative of NCDO712 9
L. lactis NZ9700 Nisin producer 14
L. lactis NZ9000 MG1363 pepN::nisRK, allows nisin-inducible expression 14
L. lactis NZ9000(acmA) Derivative of NZ9000 lacking acmA 4
L. lactis PA1001 Derivative of NZ9000 lacking acmA and htrA This study
Lactobacillus casei Wild type ATCC 393
Lactobacillus sake Wild type NCFB 2714
Lactobacillus salivarius Wild type NCFB 2747
Lactobacillus curvatus Wild type NCFB 2739
Bacillus subtilis Wild type Laboratory collection
Mycobacterium smegmatis Wild type ATCC 700084
Plasmids
pNG400 Cmr, pNZ8048 derivative containing PnisA, usp45ss, and a transcription terminator Laboratory collection
pNG3041 Cmr, pNZ8048 derivative containing PnisA, prtP preprosequence, and msa2-acmA
PA (MSA2-PA)
39
pNG3042 Cmr, pNZ8048 derivative containing PnisA, prtP preprosequence, and msa2-acmD
PA (nucleotides 1286 to 2371)b
This study
pPA1 Cmr, pNZ8048 derivative containing c-myc, B. licheniformis -amylase (amyL)
under control of PnisA, and usp45ss
This study
pPA3 Cmr, pNZ8048 derivative containing c-myc, the acmA PA (nucleotides 835 to
1492)c under control of PnisA, and usp45ss (PA3)
This study
pPA5 pPA3 derivative, B. licheniformis -amylase (amyL) upstream of the acmA PA
sequence (-PA)
This study
pPA6 (1–6) pPA3 derivative containing one to six copies of first LysM repeat of acmA PA
(nucleotides 819 to 1038)c
This study
pPA95 Cmr, pNZ8048 derivative containing c-myc, the E. coli mltD LysM repeats
(nucleotides 927 to 1313)d under control of PnisA, and usp45ss
This study
pPA165 Cmr, pNZ8048 derivative containing c-myc, human LysM repeat erap140 (amino
acids 116 to 158 [accession no. AAM27392]; in duplicate) under control of
PnisA, and usp45ss
This study
pPA171 Cmr, pNZ8048 derivative containing P. berghei CSP B-cell epitope sequences
upstream of the acmA PA sequence under control of PnisA and usp45ss; the
epitopes PPPPNPND and NANDPAPP were duplicated and fused to the PA,
[PPPPNPND]2-[NANDPAPP]2-PA (CSP[2B]-PA)
This study
pPA193 Apr, pET32c (Novagen) derivative producing CSP[2B]-His This study
pGBL1 Emr, pGB14 derivative, -lactamase secretion vector 28
pGBLR Emr, pGBL1 derivative producing secreted -lactamase fused to the AcmA PA
(-PA)
4
pINT-HtrA Emr, pORI280 derivative containing a 900-bp chromosomal DNA fragment 5 of
htrA and a 1,200-bp fragment 3 of htrA; primers used to generate the






pTOPO-htrA Apr Kmr, derivative of pCR4Blunt-TOPO (Invitrogen) containing the L. lactis
htrA gene
This study
a PnisA, nisin-inducible promoter; usp45ss, signal sequence of usp45.
b See reference 3.
c See reference 5.
d See reference 8.
e See reference 18. Sequences homologous to the MG1363 chromosome sequence are underlined.
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in 0.5% uranyl acetate. After dehydration with a graded ethanol series the
specimens were embedded in Epon (Serva). Ultrathin sections were cut with an
LKB ultramicrotome and examined with a Philips CM10 transmission electron
microscope.
For scanning electron microscopy, bacteria were fixed in 2% glutaraldehyde in
0.1 M CAC buffer (pH 7.4) for 12 h at 4°C, and this was followed by rinsing with
0.1 M CAC buffer at room temperature. Cell suspensions were spotted on clean
poly(L-lysine)-coated (0.1 to 0.2%) mica slides. After dehydration with a graded
ethanol series, samples were dried under CO2 using a critical point drier (Balzers
CPD20; Bal-Tec, Liechtenstein). Samples were Au/Pd sputter coated (Balzers
07120B; Bal-Tec), and images were obtained with a JEOL 6301-F scanning
electron microscope (JEOL Europe, Belgium) equipped with the Soft Imaging
system (PAES, Netherlands).
Vaccine preparation. Cultures of strain L. lactis(pPA171) were grown and
induced as described above to express CSP[2xB]-PA. The cell-free supernatant
was used as a source of secreted CSP[2xB]-PA. Unconcentrated cell-free culture
supernatant contained approximately 0.75 mg CSP[2xB]-PA per liter. For each
vaccine dose, 2.5  109 L. lactis GEM particles were incubated for 30 min at
room temperature with 0.8 ml of 33-fold-concentrated cell-free culture superna-
tant containing CSP[2xB]-PA. GEM particles with the bound CSP[2xB]-PA were
collected by centrifugation and washed twice in PBS. Finally, the GEM particles
were resuspended in 20 l PBS for nasal immunizations and in 100 l PBS for
subcutaneous immunizations and stored at 80°C until use. The amount of
bound CSP[2xB]-PA was estimated by using Coomassie brilliant blue-stained
gels and by comparison to BSA protein standards. Each vaccine dose contained
approximately 20 g CSP[2xB]-PA (about 1.75  105 molecules/cell).
Immunization of mice. Six-week-old female BALB/c mice (Harlan, The Neth-
erlands) were used for immunization. Groups consisted of 10 mice. Mice that
were vaccinated nasally were lightly anesthetized with 2% (vol/vol) isoflurane
over oxygen (1.2 liters/min) and NO2 (0.6 liter/min), which was administered with
a calibrated vaporizer. Anesthesia was confirmed by observation that there was
no pinch reflex reaction. Once anesthetized, the animals were scruffed, held in
the supine position, and vaccinated intranasally by placing a series of small
droplets (20 l) of the inoculum into the nostrils for the mice to involuntarily
inhale. After vaccination the mice were laid on their backs until recovery. Nasally
immunized mice received either GEM particles with CSP[2xB]-PA, GEM par-
ticles, or PBS alone. Subcutaneous immunization with GEM particles with
CSP[2xB]-PA was performed by injecting 50 l of the inoculum into each flank
under light inhalation anesthesia.
The mice were immunized on days 1, 22, and 43, and sera were collected on
days 9, 30, and 55 by orbital puncture under light anesthesia. The sera were
stored at 20°C until use.
Measurement of the serum antibody response. To determine the titer of the
antibodies against CSP[2xB], an enzyme-linked immunosorbent assay was used.
Briefly, high-binding-capacity microtiter plates (Greiner) were coated with
CSP[2xB]-His (0.2 g/well) in 0.05 M carbonate buffer (pH 9.6) overnight at 4°C.
The plates were washed with PBS (pH 7.4) with 0.02% Tween 20 and then
incubated for 1 h with 5% BSA in PBS-Tween. Sera were diluted appropriately,
threefold dilutions were added to the plates, and the plates were incubated for
2 h at room temperature. After washing, the alkaline phosphatase secondary
antibody directed to mouse IgG-Fc (Sigma) was incubated for 1.5 h at a dilution
of 1:5,000. A colorimetric reaction was obtained by addition of p-nitrophenyl
phosphate substrate (Sigma) diluted in 0.05 M carbonate buffer (pH 9.6) con-
taining 0.001 mM MgCl2. The enzymatic reaction was stopped with NaOH, and
the results were read at 405 nm. Concentrations were calculated from a calibra-
tion curve prepared with purified mouse IgG (Sigma).
RESULTS AND DISCUSSION
PA-mediated surface display. The three LysM motifs in the
AcmA PA are responsible for binding to the cell wall pepti-
doglycans of various gram-positive bacteria (39). The N-termi-
nal part of the protein is thus exposed to the outer surface of
the cell wall. It was found that exogenous addition of a hybrid
protein containing PA (i.e., one PA C-terminally fused to
MSA2 [MSA2-PA], a malaria parasite merozoite-stage surface
antigen) caused specific binding to L. lactis cells. MSA2-PA
bound to the cell poles of living cells, whereas it was able to
bind to the entire cell surface when the cells were first boiled
in TCA and washed with PBS prior to addition of the fusion
protein (39). The resulting TCA-pretreated L. lactis cells, des-
ignated GEM particles, exhibited considerably increased bind-
ing capacity for PA fusions (see below). The method described
here for preparation of GEM particles is generally applicable
to gram-positive bacteria. We obtained similar results for L.
lactis and Lactobacillus casei using MSA2-PA (39) and also
using other PA fusion proteins, like PA3 (see below), with
various other gram-positive bacteria, including Lactobacillus
sake, Lactobacillus salivarius, Lactobacillus curvatus, B. subtilis,
and M. smegmatis (data not shown).
In addition to the AcmA PA, a number of alternative LysM-
type PAs were produced as c-Myc fusions and tested for their
ability to bind to lactococcal GEM particles. The LysM do-
mains included are the peptidoglycan-binding motifs of (i) the
membrane-bound lytic transglycosylase MltD from E. coli (8)
(two LysM sequences), (ii) the putative peptidoglycan hydro-
lase AcmD of L. lactis (3) (three LysM sequences), and (iii) a
human LysM domain present in the estrogen receptor-associ-
ated protein ERAP140 (38) (one LysM sequence, but it is
expressed here as a duplicate). Lactococcal GEM particles
were incubated with L. lactis PA1001 cell-free culture super-
natant containing these LysM-type PAs fused to the c-Myc
epitope. Western blot analysis of the GEM particles and su-
pernatant fractions after binding revealed that all the non-
AcmA PA domains exhibited no or only poor binding, whereas
all of the AcmA PA was completely bound to the GEM par-
ticles (data not shown). Thus, under the conditions used even
the lactococcal AcmD PA homolog exhibited poor binding.
Since AcmA PA can be bound to various gram-positive bacte-
ria, it seems to have relaxed peptidoglycan binding specificity,
while non-AcmA PAs exhibit a higher degree of specificity or
require more specific binding conditions.
On the basis of these results we developed a broadly appli-
cable surface display system which takes advantage of the abil-
ity of AcmA PA-containing proteins to bind noncovalently to
lactococcal GEM particles. PA-mediated surface display dif-
fers in a number of aspects from bacterial surface display
systems that have been described previously (36). First, the
strain for production of PA-containing hybrid proteins and the
host strain for surface display can be different, allowing the use
of a non-GMO display strain. In contrast, previously described
bacterial display systems rely on recombinant host strains to
which the anchoring domain is covalently attached to the cell
surface during translocation (16). Second, the AcmA PA has a
high affinity for gram-positive cell walls, and L. lactis growth
medium contains only a few other proteins (3). Therefore, the
cell-free culture medium is directly suitable for addition to
lactococcal GEM particles, and further purification steps are
FIG. 1. Schematic diagram of the organization of the general dis-
play vector pPA3. Abbreviations: PNisA, inducible nisA promoter;
usp45ss, usp45 signal sequence; c-myc, region encoding an epitope for
immunodetection; MCS, multiple cloning site. Cross-hatched boxes
indicate the LysM repeat sequences.
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not necessary. Finally, AcmA PA fusions can be bound to
living as well as nonliving gram-positive bacteria. Moreover,
PA fusions bound to GEM particles were found to be very
stable. No loss or degradation of the PA fusion was observed
during storage of the loaded GEM particles in PBS at room
temperature, 4°C, and 80°C (41).
PA display vector. In order to create a generally applicable
PA fusion system, we constructed the versatile surface display
vector pPA3. This vector has the following parts (Fig. 1): the
lactococcal pNZ212 origin of replication; a chloramphenicol
acetyltransferase gene for selection; the PnisA promoter to di-
rect inducible expression of PA fusions (7); the lactococcal
Usp45 signal sequence to drive secretion (40); the c-Myc
epitope, which was included for detection of secreted protein;
a multiple cloning site to allow insertion of recombinant genes;
and the gene fragment encoding the PA (C-terminal 218-ami-
no-acid cell wall-binding domain of AcmA of L. lactis, as de-
scribed by Buist et al. [5]), including its stop codon and tran-
scriptional terminator. L. lactis strains carrying pPA3 secrete
the c-Myc–PA fusion (PA3) into the growth medium upon
induction of the promoter.
L. lactis NZ9000 and NZ9000(acmA) appeared not to be
efficient hosts for the production of full-length PA3 since PA
degradation products were observed in the growth medium
(data not shown). These degradation products were most likely
due to the activity of the surface-located housekeeping pro-
tease HtrA, which has been shown to degrade the AcmA cell
wall-binding domain (4, 5, 26, 29). Efficient production of full-
length PA3 was obtained by using an htrA-deficient L. lactis
strain. To this end, a deletion in the chromosomal copy of htrA
of L. lactis NZ9000(acmA) was made using the pORI280
replacement recombination system (18). The resulting strain,
L. lactis PA1001, was used for production of PA derivatives
throughout this study. L. lactis PA1001(pPA3) produced and
secreted only full-length PA3, only a small part of which was
bound to the L. lactis production cells. Most of the PA3 was
secreted as soluble protein into the culture supernatant. L.
lactis PA1001(pPA3) produced about 10 mg PA3 per liter
GM17, as estimated from Coomassie brilliant blue-stained
SDS-PAA gels (data not shown).
Maximum binding capacity of lactococcal GEM particles.
Purified PA3 was used to determine the maximum binding
capacity of lactococcal GEM particles. Different amounts of
purified PA3 (20 to 160 g) were added to 2.5  109 lactococ-
cal GEM particles in 1 ml PBS. Standard binding conditions
were used as described in Materials and Methods. After bind-
ing, the GEM particles were separated from the supernatant
by centrifugation and washed twice with 1 ml PBS. Subse-
quently, the amount of PA3 on the GEM particles and the
FIG. 2. Fluorescence microscopic (A and B), scanning electron
microscopic (C and D), and transmission electron microscopic (E and
F) images of L. lactis cells and L. lactis GEM particles. (A, C, and E)
Untreated cells; (B, D, and F) GEM particles. Typical examples are
shown. The samples in panels A and B contained bound PA3. The bar
in panel D represents 1 m. (G) Coomassie brilliant blue-stained
SDS-PAA gel of total protein extracts of 5  108 L. lactis cells (lane 1)
and an equal number of L. lactis GEM particles (lane 2). The sizes of
the marker proteins (lane M) (in kDa) are indicated on the left.
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amount of the PA3 remaining in the supernatant were ana-
lyzed using Coomassie brilliant blue-stained SDS-PAA gels.
Control samples containing nontreated L. lactis cells (which
bound very little PA3 [Fig. 2A]) or containing no cell particles
were included in the analyses to exclude nonspecific entrap-
ment of PA3 between particles and nonspecific binding of PA3
to the reaction vials, respectively. These analyses showed that
140 to 150 g PA3 bound specifically to the GEM particles;
with these amounts no PA3 was found in the supernatant,
whereas most PA3 (
 90%) and all PA3 remained in the
supernatants of the nontreated L. lactis cells and the no-par-
ticle control samples, respectively. After addition of more than
150 g PA3 some PA3 remained in the supernatant after
binding. These results indicated that under the conditions used
at most 150 g PA3 can bind to 2.5  109 lactococcal GEM
particles. Thus, GEM particles saturated with PA3 (molecular
mass, 28 kDa) contained about 106 PA3 molecules per cell.
The amount may be smaller for PA fused to more bulky
polypeptides. Nevertheless, the surface density of PA3 on
GEM particles compares favorably with the surface densities
for other surface display systems, which rely on expression of
proteins on the surface of bacterial cells or spores. For exam-
ple, surface densities of 104 and 1.5  103 molecules per cell
have been reported for Staphylococcus carnosus (1) and B.
subtilis spore (13) surface display systems, respectively.
Influence of the number of LysM motifs in the PA on bind-
ing. The AcmA PA consists of three LysM motifs (5). In the
LysM protein family the number of LysM repeat motifs varies
between 1 and 12. Proteins containing multiple LysM motifs
are considered multivalent with the potential to bind to their
substrates with high affinity. PA, for example, binds very
strongly to its natural substrate, the L. lactis cell wall. Bound
PA was only partially removed from GEM particles after treat-
ment with 8 M LiCl (not shown). This compound is commonly
used to remove noncovalently bound proteins from bacterial
cell walls. Thus, although PA binds to bacterial cell walls in a
noncovalent manner, the binding interactions appear to be
very strong.
In order to test the effect of the number of LysM repeats on
cell wall binding, we first expressed and secreted a single bind-
ing module, PA6, comprising the first LysM motif and spacer
of the PA (amino acid residues 215 to 287; AcmA numbering
as described by Buist et al. [5]). This single binding module was
able to bind to GEM particles. However, binding was poor
since a considerable amount of PA6 remained in the superna-
tant after binding (data not shown). Subsequently, PA6 mod-
ules were added one by one in chimeric constructs, yielding
concatemers consisting of up to six PA6 modules (nPA6, with
n  1 to 6). All the nPA6 chimeras were secreted by L. lactis
PA1001, and supernatants containing the different concatem-
ers were used to analyze binding to L. lactis GEM particles.
SDS-PAGE analysis of PA6 concatemers showed that proteins
containing up to four PA6 modules were produced at compa-
rable levels (data not shown). Production of 5PA6 and 6PA6
was considerably lower. The lower protein yields could be
related to proteolytic degradation of the proteins, as well as to
plasmid instability (data not shown).
Binding of PA6 concatemers to GEM particles was moni-
tored colorimetrically (Fig. 3). In this case, binding was de-
tected using the c-Myc tag as a reporter. Different amounts of
PA6 concatemers carrying an N-terminally exposed c-Myc tag
were allowed to bind to lactococcal GEM particles. As ex-
pected, the lowest level of binding was found for 1PA6. In
other experiments we determined that 1PA6 without a spacer
domain (amino acid residues 243 to 286; AcmA numbering as
described by Buist et al. [6]) still bound to GEM particles,
albeit with lower affinity. The spacer domain itself (amino acid
residues 215 to 242; AcmA numbering as described by Buist et
al. [5]) did not show binding to GEM particles (data not
shown). A steep increase in binding affinity was obtained by
addition of a second PA6 domain, and the level was even
somewhat higher than that for wild-type PA3 (Fig. 3). Three
PA6 modules exhibited binding affinity similar to that of the
wild-type PA3, whereas addition of a fourth domain had a
negative effect on the binding affinity.
In summary, strong binding to lactococcal GEM particles
was already obtained with two PA6 modules (i.e., two identical
AcmA LysM domains).
Lactococcal GEM particles. In the method to generate lac-
tococcal GEM particles that was initially described 10% TCA
is used. This acid is commonly used for purification of pepti-
doglycan from cell wall extracts. TCA is known to specifically
remove (lipo)teichoic acids from cell walls. It has been pro-
posed that these cell wall components prevent PA from bind-
ing to the cell surface (39).
For some applications TCA may be a less desirable chemical
for use in large-scale production of GEM particles. A number
of alternative acids were examined, including HCl, acetic acid,
lactic acid, and some other chemicals generally used for puri-
fication of cell wall peptidoglycan. The acid concentration was
optimized to prevent cellular lysis. The effect of various chem-
ical treatments on the loading capacity of GEM particles was
FIG. 3. Colorimetric assay for detection of surface-displayed PA6
concatemers on lactococcal GEM particles. Different amounts of PA6
concatemers were added to 2.5  109 GEM particles. After binding,
particles were collected by centrifugation and washed twice with PBS
buffer. Surface-displayed PA6 concatemers were detected with horse-
radish peroxidase-conjugated anti-c-myc antibody (Roche). GEM par-
ticles were washed three times with PBS and developed with 1 ml of
the horseradish peroxidase substrate 2,2-azinobis(3-ethylbenzthiazo-
linesulfonic acid (ABTS) (Fluka)–H2O2. Absorbance at 405 nm was
determined after a suitable time. ■, PA6; Œ, 2PA6; F, 3PA6; , 4PA6;
}, PA3.
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investigated using a fusion protein consisting of -amylase
from Bacillus licheniformis and PA (-PA). -PA was function-
ally displayed on the surface of lactococcal GEM particles (see
below). Culture medium containing -PA was added to chem-
ically pretreated lactococcal cells. -PA bound to GEM parti-
cles was visualized by incubating loaded GEM particles with
the chromogenic amylase substrate amylase azure. The absor-
bance at 595 nm was a measure of the amount of bound -PA.
The results, summarized in Fig. 4, clearly show that all of the
acids tested were equally effective at the concentrations indi-
cated in improving the loading capacity of L. lactis cells. Com-
pared to nonpretreated L. lactis cells, 10- to 15-fold increases
in absorbance were obtained with GEM particles, illustrating
the greater loading capacity of the GEM particles. Pretreat-
ment of lactococcal cells with a number of chemicals generally
used for purification of cell wall peptidoglycan, such as phenol,
guanidine hydrochloride, and SDS, did not affect the loading
capacity of the cells (not shown). All the treatments with the
acids and other chemicals tested resulted in complete killing of
the lactococcal cells (plating efficiency, 0).
Fluorescence and electron microscopic analyses of L. lactis
cells pretreated with 10% TCA showed that the harsh treat-
ments left the cellular morphology largely intact (Fig. 2A to
D). Similar results were obtained with cells treated with HCl,
H2SO4, and HAc (data not shown). Due to the acid pretreat-
ment, binding of PA3 occurred on the entire cell surface,
whereas in nonpretreated cells PA3 bound only to the cell
poles (Fig. 2A and B). This clearly illustrated the increased
binding capacity of lactococcal GEM particles.
The harsh acid pretreatment of the lactococcal cells most
likely affected the protein and DNA contents of the GEM
particles. The intracellular contents of the GEM particles
seemed to be partially released or degraded (Fig. 2E and F).
Similar results were obtained for all acids tested; however, the
optimal acid concentrations could differ for each acid (41).
Figure 2G shows a typical example of an SDS-PAGE analysis
of proteins from lysed acid-pretreated cells. Substantial
amounts of proteins were removed from the GEM particles
and/or degraded. The DNA content of lactococcal GEM par-
ticles was determined by RTQ-PCR. Total DNA isolated from
approximately 2.5  109 nontreated L. lactis cells or lactococ-
cal GEM particles was used as the template. Three separate
runs of RTQ-PCR were performed to determine the DNA
content of lactococcal cells. For nontreated L. lactis cells an
average of one to two copies of the htrA gene per cell was
calculated, which is close to the theoretical value (one copy).
For GEM particles we calculated that for each particle there
was about 106 copy of the htrA gene. In other words, in only
1 cell out of 106 GEM particles was a copy of the htrA gene
present. This indicated that acid pretreatment of L. lactis cells
degrades or removes almost all DNA from the cells.
In conclusion, lactococcal GEM particles are nonviable
spherical peptidoglycan microparticles with a diameter of ap-
proximately 1 m. They have a lower protein content, contain
virtually no DNA, can be generated by boiling in various acids,
and exhibit enhanced binding capacity for PA fusions.
Applications of the GEM particle-PA display system. (i)
Immobilizing enzymes. Due to the enhanced binding capacity
of L. lactis GEM particles and their nonproteolytic character,
the GEM particle-PA system could provide an attractive alter-
native method for immobilizing enzymes. Enzymes can be at-
tached to GEM particles by fusion to the PA. To test this, we
used B. licheniformis -amylase (AmyL) as a reporter enzyme.
The -PA fusion was bound to GEM particles. PA3 and wild-
type AmyL incubated with GEM particles were used as con-
trols. Amylase activity assays clearly demonstrated that -PA
was functionally displayed on the surface of GEM particles
(Fig. 5a). As expected, no significant amylase activity was ob-
served with GEM particles loaded with PA3 or with GEM
particles incubated with supernatant containing AmyL (Fig.
5a).
Exogenous addition of PA fusions to lactococcal GEM par-
ticles allows controlled surface display of multiple proteins, in
contrast to previously described surface display systems, which
are based on expression of proteins on the cell surface. In these
cases display of multiple proteins would require large plasmid
constructs encoding multiple proteins or multiple plasmids in a
single host organism. Moreover, the display level is largely
dependent on the efficiency of expression and translocation.
With PA-mediated surface display these problems are circum-
vented since display of multiple proteins can be achieved easily
by incubating GEM particles with culture medium containing
different PA fusions. This was illustrated by displaying two
enzymes, B. licheniformis -amylase (-PA) and E. coli -lac-
tamase (-PA), together on GEM particles. Different volumes
of cell-free culture supernatant containing -PA or -PA were
added, sequentially or premixed, to the GEM particles. Sur-
face display of both -PA and -PA was visualized by assaying
enzyme activity using the chromogenic substrates amylase
azure and nitrocefin, respectively. The results are summarized
in Fig. 5b and show that both enzymes were active when they
were immobilized individually on lactococcal GEM particles
(groups A and B). The cell-free culture supernatant volumes
with -PA used in groups C to E were the same as the volume
used in group B, whereas the cell-free culture supernatant
volumes used with -PA varied; in group C the volume was
one-third the volume in group A, in group D the volume was
two-thirds the volume in group A, and in group E the volume
FIG. 4. Effect of different acid pretreatments on the binding capac-
ity of L. lactis particles. -PA was added to an equal number of GEM
particles. Bound -PA was determined with the chromogenic substrate
amylose azure. Bar A, no treatment; bar B, 10% TCA; bar C, 0.2%
TCA; bar D, 5.6 M HAc; bar E, 0.01 M HCl; bar F, 0.72 M lactic acid;
bar G, 0.56 M formic acid. The means for three determinations (15%
difference) are shown.
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was the same as the volume in group A. The increase in -PA
activity correlated nicely with the added volume of culture
supernatant, indicating that there were increased amounts of
-PA on the GEM particles. Strikingly, the amylase activities
in groups C to E were higher than expected since the same
amounts of -PA were bound in these groups as in group B.
The reason for this observation is not clear at present, and
investigating it in more detail was beyond the scope of this
study.
The results demonstrated that externally added enzymes can
be functionally immobilized on lactococcal GEM particles by
fusing them to the PA. In addition, combinations of enzymes
can be immobilized in controlled ratios. Immobilization of PA
fusions is fast and easy with no need for chemical treatments or
extensive purification steps.
(ii) Mucosal vaccine delivery. The use of bacterial surface
display systems for the development of vaccines is an emerging
research area (16). Heterologous antigens have been displayed
on bacterial cells in order to elicit antigen-specific antibody
responses. Recently, mucosal vaccination using bacterial dis-
play systems has received a great deal of attention (6, 10, 20,
21). However, current systems for bacterial surface display are
based on attenuated pathogenic strains and/or recombinant
bacteria (25). The potential abilities of these (attenuated or
recombinant) bacterial strains to flourish on or invade mucosal
surfaces may cause problems, such as inflammation and dis-
ease or possibly the induction of immune tolerance. Further-
more, the presence of recombinant DNA in such vaccines may
be considered less desirable because of shedding of the recom-
binant DNA into the environment and the possible risk of
transmission to other organisms. Vaccines based on the GEM
particle-PA display system eliminate some of the drawbacks
associated with the use of genetically modified bacterial deliv-
ery systems.
In order to evaluate the efficacy of the GEM particle-PA
display system as a mucosal delivery tool, a nasal vaccine was
constructed on the basis of the circumsporozoite surface anti-
gen (CSP) of the Plasmodium berghei malaria parasite (33).
The CSP epitopes PPPPNPND and NANDPAPP, both fused
as duplicates in one construct to the PA (CSP[2xB]-PA), were
bound to GEM particles. This vaccine was nasally adminis-
tered to mice without the use of an additional adjuvant. The
mice were immunized three times at 3-week intervals. For
comparison, another group of mice was subcutaneously immu-
nized with the same vaccine and dose using the same immu-
nization schedule. The mice received a total of 60 g
CSP[2xB]-PA in the three immunizations. Control groups con-
sisted of groups of mice that received GEM particles or only
PBS nasally. Sera collected 8 to 12 days after each immuniza-
tion were used to detect CSP[2xB]-specific IgGs with an en-
zyme-linked immunosorbent assay. CSP[2xB]-specific serum
IgGs were detected only in the mice that received GEM par-
ticles loaded with CSP[2xB]-PA (Fig. 6). In the subcutaneously
immunized mice the CSP[2xB]-specific IgG levels reached ap-
proximately 4, 24, and 35 g/ml after the first, second, and
FIG. 5. Immobilization of enzymes on the surface of lactococcal GEM particles. (a) Relative -amylase activities on GEM particles incubated
with culture medium containing soluble AmyL, PA (PA3), or -PA. (b) Relative -amylase and -lactamase activities on GEM particles carrying
-PA and -PA at different ratios. Sample A, incubation with 1 volume of cell-free culture supernatant containing -PA; sample B, incubation with
1 volume of cell-free culture supernatant containing -PA; sample C, incubation with 1 volume of cell-free culture supernatant containing -PA
and 1/3 volume of -PA; sample D, incubation with 1 volume of cell-free culture supernatant containing -PA and 2/3 volume of -PA; sample
E, incubation with 1 volume of cell-free culture supernatant containing -PA and 1 volume of -PA. The mean value for three determinations
(15% difference) was normalized to the activities for samples A and B, which were defined as 100%. Solid bars, nitrocefin as the substrate
(specific for -lactamase activity); gray bars, amylose azure as the substrate (specific for -amylase activity).
FIG. 6. IgG-specific serum antibody response to the CSP[2xB]
epitopes. Groups of 10 mice were immunized nasally or subcutane-
ously with GEM particles (CSP[2xB]-PA). The sera were obtained as
described in Materials and Methods.
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third immunizations, respectively. The nasal GEM particle
(CSP[2xB]-PA) vaccine induced a weak but significant
CSP[2xB]-specific IgG response after the first immunization
(0.2 g/ml). However, a steep increase in the CSP[2xB]-spe-
cific IgG level was observed after the second immunization (65
g/ml), which increased to approximately 120 g/ml after the
third immunization.
These results clearly show the potential of the GEM parti-
cle-PA display system as a delivery vehicle for mucosal vac-
cines and that this system can be used to elicit antigen-specific
systemic antibodies. In addition, the results demonstrate that
an antigen produced at a relatively low level (0.75 mg/liter) can
be efficiently concentrated on GEM particles in a simple pro-
cess using the PA binding domain and thus create an effective
immunogen.
Conclusions. Lactococcal GEM particles are a suitable non-
living, non-GMO support for the display of proteins for various
applications. L. lactis is an organism that is generally recog-
nized as safe because it has a long history of safe use in foods
(34), and large quantities can be easily cultivated. Acid pre-
treatment can be done with various acids, including acids that
are compatible with the use of GEM particles in humans.
Several applications can be envisaged. Immobilized enzymes
can be used in industrial processes, diagnostic kits, or foods or
to clean up environmental spills. The ability to bind multiple
different proteins or peptides at a controlled ratio on a single
GEM particle can be an additional advantage compared to
existing particle systems. Also, the high loading capacity and
high binding affinity are advantageous. The GEM particle-PA
system might also be used for purification purposes, although
a proper elution buffer has not been identified yet. So far,
complete elution has been obtained only with SDS-containing
solutions, which makes downstream processing difficult. This
difficulty could be circumvented by incorporation of a protease
recognition site between the PA and the desired protein, as has
been done for similar affinity-based purification systems. For
applications in mucosal vaccines the GEM particle-PA system
combines the advantage of recombinant live bacterial delivery
systems (i.e., presentation of antigens by a bacterial particle)
with the advantage of inert microparticle delivery systems (i.e.,
safety).
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